LONDON and LOS ANGELES and COPENHAGEN, Denmark, July 10, 2025 /PRNewswire/ — SunsolveMD by TheSolveMD, the skin health brand pioneering the future of SPF, announces the global expansion of its patented clinical skincare system into the U.S. and GCC markets. Already stocked in Harrods, Liberty London, John Bell & Croyden (UK) and Bergdorf Goodman, Bluemercury, Moda Operandi (USA), SunsolveMD enters its next phase backed by its proprietary biotech platform, SolveTech™, and led by a founding team comprising a surgeon, a biomedical engineer, and a cosmetic chemist.
Developed across its Los Angeles laboratory and Danish skin engineering hub, SunsolveMD by TheSolveMD is one of the only vertically integrated skincare platforms operating with full in-house control — from IP development to clinical validation and formulation design.
“We didn’t start with a marketing story. We started with a patent,” said a spokesperson for TheSolveMD. “Our products are not outsourced. They’re engineered molecule by molecule to correct and protect skin from the inside out.” – Frederik Skovgaard, Chief Engineering Officer.
The SolveTech™ Platform: Where Biotech Meets Beauty
At the core of SunsolveMD by TheSolveMD is SolveDNAReverse™, a patented complex designed to preserve DNA integrity and support cellular repair in skin exposed to UV, pollution, and oxidative stress.
The SolveTech™ innovation stack also includes:
- MelaFix™ – A tyrosinase-regulating pigment correction system for melasma and PIH
- CeraPol-3™ – A post-procedure safe barrier-repair lipid complex
- Lipiderma™ – A volumising and hydrating peptide complex for lips with SPF30
- LipidRestore Complex – Used in Volumize + Restore, a high-SPF fluid serum that rebuilds depleted skin structure while shielding from daily environmental damage
All formulas feature 12% non-nano Zinc Oxide, photostable and transparent across all Fitzpatrick skin types — with no chemical filters, and no compromise.
Clinical-Grade, Collection-Driven
SunsolveMD by TheSolveMD’s SPF systems are structured into three proprietary ranges:
- ZnO+ Mineral Care – SPF50+ face and eye protocols formulated to treat acne, pigmentation, dehydration, and inflammation through targeted actives and mineral protection
- ZnO+ AntiOxtint – Tinted SPF50+ in six adaptable shades with Dermo-Vitaplex™, offering skincare, protection, and makeup compatibility in one
- LipidRestore – A clinical innovation line including Volumize + Restore (face) and Volumize + Condition (lip), designed to restore dermal bounce, lip volume, and long-term skin resilience
A New Standard in Protection
SunsolveMD by TheSolveMD is clinically tested, cruelty-free, fragrance-free, and developed to integrate seamlessly with actives, peels, injectables, and post-laser recovery. With only 13.5% of Americans using SPF daily, despite 1 in 5 developing skin cancer by age 70, SunsolveMD exists to reframe protection as the foundation of modern skin health.
“SPF has long been marketed as cosmetic. For us, it’s a clinical necessity — grounded in real science, built on real patents, and designed to protect real skin,” the brand’s spokesperson added. ” – Frederik Skovgaard, Chief Engineering Officer.
Elsa Hosk Joins SunsolveMD as Global Ambassador
Entrepreneur and supermodel Elsa Hosk leads SunsolveMD as its first Global Brand Ambassador, bringing personal experience, product development inspiration and international reach. Having grown up in Sweden with fair, sun-sensitive skin and limited SPF options, Hosk found in SunsolveMD a rare fusion of high protection, elegant texture, and real skin care.
“I’m genuinely obsessed with this formula,” said Hosk. “It gives me serious protection, but it also hydrates, brightens, and leaves my skin feeling smooth, calm, and glowing. It’s the first sunscreen I actually want to apply every day.”
“Elsa embodies everything SunsolveMD stands for: clinical precision, elevated beauty, and uncompromising intelligence,” said Portia Dieguez, Chief Strategy Officer at TheSolveMD. “She understands what it means to protect your skin with intention. That’s the future of SPF.”
About SunsolveMD by TheSolveMD
SunsolveMD by TheSolveMD is a biotech-first skincare platform founded by a surgeon, engineer, and chemist, developed across in-house laboratories in Los Angeles and Copenhagen. The brand formulates clinical-grade SPF systems powered by proprietary IP including SolveDNAReverse™, MelaFix™, and Lipiderma™, with every SKU created internally, tested rigorously, and sold globally.
SunsolveMD is available at leading retailers including Harrods, Liberty, John Bell & Croyden, Bergdorf Goodman, Bluemercury, and Moda Operandi, and will expand into further global markets in 2026.
View original content to download multimedia:https://www.prnewswire.com/news-releases/sunsolvemd-by-thesolvemd-and-elsa-hosk-redefine-sun-protection-with-in-house-biotech-innovation-302502799.html
SOURCE SunSolve MD
